Actinomycosis secondary prevention: Difference between revisions

	Actinomycosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Actinomycosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Actinomycosis secondary prevention On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Actinomycosis secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Actinomycosis secondary prevention
CDC on Actinomycosis secondary prevention
Actinomycosis secondary prevention in the news
Blogs on Actinomycosis secondary prevention
to Hospitals Treating Actinomycosis
Risk calculators and risk factors for Actinomycosis secondary prevention

Revision as of 15:24, 30 March 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

There are no secondary prentive measures available for actinomycosis.

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{Actinomycosis}}
-Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
+{{CMG}};{{AE}}{{ADG}}
+==Secondary prevention==
+There are no secondary prentive measures available for actinomycosis.
 ==References==
@@ Line 26: / Line 28: @@
 [[Category:Overview complete]]
 [[Category:Dermatology]]
+ion